BioNTech's statement on patent infringement lawsuit filed by Moderna
- Details
- Category: Business

Moderna sues Pfizer and BioNTech for infringing patents central to Modernas innovative mRNA technology platform
- Details
- Category: Business

Positive Phase 1 data from mRNA-based individualized neoantigen specific immunotherapy in patients with resected pancreatic cancer
- Details
- Category: Business

Nearly 700,000 US hospitalizations and 110,000 deaths prevented from the Pfizer-BioNTech COVID-19 vaccine
- Details
- Category: Business
The profound health and economic impact of the Pfizer-BioNTech vaccine during its first year of rollout in the US is described in detail in a new study in the peer-reviewed Journal of Medical Economics.
It is estimated that in 2021 the vaccine, the most widely used against COVID-19 in the US, prevented 8.7 million symptomatic cases of the virus, as well as 690,000 hospitalizations and more than 110,000 deaths.
Pfizer and BioNTech provide update on COVID-19 vaccine supply agreement with European Commission
- Details
- Category: Business

Pfizer and BioNTech receive expanded U.S. emergency use authorization for an additional COVID-19 vaccine booster in individuals aged 50 years and older
- Details
- Category: Business

Statement on humanitarian aid in Ukraine
- Details
- Category: Business

More Pharma News ...
- BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
- BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
- Pfizer and BioNTech sign new global collaboration agreement to develop first mRNA-based shingles vaccine
- Leiden University Medical Center and Intravacc to start clinical trial with new intranasal corona vaccine
- European Commission grants conditional marketing authorization for Novavax COVID-19 vaccine
- Pfizer and BioNTech receive expanded U.S. FDA emergency use suthorization of COVID-19 vaccine booster to include individuals 18 and older
- Petrovax Pharm is taking part in the international pharmaceutical exhibition CPhI Worldwide-2021